New Urine Test Could Diagnose Eye Disease
You might not think to look to a urine test to diagnose an eye disease.But a new Duke University study says it can link what is in a patient's urine to gene mutations that cause retinitis pigmentosa, or RP, an inherited, degenerative disease that results in severe vision impairment and often blindness. (Source: Medical Design Online News)
Source: Medical Design Online News - October 10, 2013 Category: Medical Equipment Source Type: news
New urine test could diagnose eye disease
(Duke University) You might not think to look to a urine test to diagnose an eye disease. But a new Duke University study says it can link what is in a patient's urine to gene mutations that cause retinitis pigmentosa, or RP, an inherited, degenerative disease that results in severe vision impairment and often blindness. The findings appear online in the Journal of Lipid Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 8, 2013 Category: Global & Universal Source Type: news
FDA-approved bionic eye Argus II aims to restore some vision in the blind
Argus II helps people suffering from degenerative eye disease retinitis pigmentosa see the difference between light and dark (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 7, 2013 Category: Consumer Health News Source Type: news
NHS England moots ‘bionic eye’ treatment for blindness caused by retinitis pigmentosa
Argus II is the world’s first approved device intended to restore some functional vision for people suffering from blindness due to outer retinal degenerations. More .... (Source: NHS Networks)
Source: NHS Networks - September 17, 2013 Category: UK Health Authors: Maria Axford Source Type: news
Amarantus reports positive data for MANF in retinitis pigmentosa
Biotechnology company Amarantus BioScience Holdings has reported positive data for Mesencephalic-Astrocyte-derived neurotrophic factor (MANF) in retinitis igmentosa (RP), a degenerative disease. (Source: Drug Development Technology)
Source: Drug Development Technology - August 13, 2013 Category: Pharmaceuticals Source Type: news
Retina Implant AG's Alpha IMS Wins CE Mark
Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that its wireless subretinal implant technology, the Alpha IMS, has received CE Mark. Retina Implant's technology, which has been in clinical trials across the world since 2005, is designed to restore useful vision in patients blinded by the degenerative eye condition retinitis pigmentosa (RP). To date, 36 patients have received the Alpha IMS microchip. This is the first European regulatory certification for the Company and the Alpha IMS device... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 5, 2013 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
Retina Implant AG's Alpha IMS Wins CE Mark
First Wireless Subretinal Device to Restore Useful Vision in Patients Blinded by Retinitis Pigmentosa
REUTLINGEN, Germany, July 3, 2013 -- (Healthcare Sales & Marketing Network) -- Retina Implant AG, the leading developer of subretinal implants for pat... Devices, Ophthalmology, RegulatoryRetina Implant AG, subretinal implant, retinitis pigmentosa, Alpha IMS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2013 Category: Pharmaceuticals Source Type: news
University Hospitals Eye Institute to offer 'first bionic eye' retinal chip for blind
(University Hospitals Case Medical Center) University Hospitals Eye Institute will be one of the first medical centers in the United States to offer the Argus® II Retinal Prosthesis System ("Argus II"). The Argus II is the first and only "bionic eye" to be approved in countries throughout the world, including the US. It is used to treat patients with late stage retinitis pigmentosa. Argus II was developed by Second Sight Medical Products, Inc., located near Los Angeles. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 27, 2013 Category: Global & Universal Source Type: news
Engineered Virus Will Improve Gene Therapy For Blinding Eye Diseases
Researchers at the University of California, Berkeley, have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration. Unlike current treatments, the new procedure - which takes a little as 15-minutes - is surgically non-invasive, and it delivers normal genes to difficult-to-reach cells throughout the entire retina... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 16, 2013 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
Easy Effective Therapy to Restore Sight Developed by Researchers
Researchers at the University of California, Berkeley, have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration. (Source: Disabled World)
Source: Disabled World - June 12, 2013 Category: Disability Tags: Vision Disability Source Type: news
Irish Biopharm Firm Gets Orphan Drug Designation From FDA
Dublin biopharmaceutical company Genable Technologies has been granted orphan drug designation from the Federal Drug Administration (FDA) in the US for its gene therapy product GT308 that it is developing to treat the eye disease retinitis pigmentosa. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 16, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
Electronic Eye Implant Gives Hope To The Blind
Promising results have shown that blind patients have regained their sight with a sub-retinal microchip, according to the first part of the second clinical trial for the device taking place in Germany. The patients involved in the study, published in the Proceedings of the Royal Society, were blinded by retinitis pigmentosa (RP) and used the implant in and outside of their homes. Retinitis pigmentosa is one of the most common types of inherited retinal degenerations and affects nearly 1.5 million people around the world... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 20, 2013 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
Second Test Of Retinal Implant Shows Restored Vision To The Blind
Retinitis pigmentosa is a genetic disease that causes people to slowly lose their eyesight as time goes on and eventually become blind. This causes the cells in the eye that receive and transmit light information to die over time. However, the rest of the eye's visual functions are intact. So there are a lot of researchers working to restore vision in these patients by developing an artificial implant that can take the place of those lost cells. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 20, 2013 Category: Pharmaceuticals Authors: Alex Knapp Source Type: news
Retinal implant restores partial sight to blind people
Some previously blind patients fitted with retinal implant could read signs, tell the time and distinguish white wine from redBlind people have described smiles on friendly faces, the food on their plates, and household objects from telephones to dustbins, after surgeons fitted them with electronic chips to partially restore their vision.Results from the first eight patients to enrol in a clinical trial of the retinal implants show that five found the chips improved their eyesight enough to be useful in everyday life.All those involved – men and women aged 35 to 62 – had lost their sight to retinitis pigmentosa, a here...
Source: Guardian Unlimited Science - February 20, 2013 Category: Science Authors: Ian Sample Tags: World news Health guardian.co.uk Medical research Human biology Society Neuroscience UK news Disability Blindness and visual impairment Source Type: news
Light-sensing chip replaces damaged cells in eye – video
An electronic chip measuring 3mm square has been implanted behind the retina of patients left blind by retinitis pigmentosa (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 20, 2013 Category: Science Tags: Biology Health guardian.co.uk Medical research Human biology Society Neuroscience Blindness and visual impairment Editorial Source Type: news
